Neonatal Abstinence Syndrome

This is a complex and pressing issue—infants born to mothers with substance use disorders. Participants will explore the multifaceted challenges of Neonatal Abstinence Syndrome (NAS), delving into the physiological, pharmacological, and developmental aspects. The importance of early identification, comprehensive assessment, and compassionate care for neonates affected by NAS. Attendees will engage in discussions on evidence-based treatment approaches, including pharmacotherapy and non-pharmacological interventions, to ease withdrawal symptoms and support neurodevelopment. This addresses the collaborative role of healthcare providers, social services, and families in creating a nurturing environment for neonates born into these circumstances. The participants equip themselves to address NAS with sensitivity and expertise, promoting the well-being of both infants and families. Join us to expand your understanding of Neonatal Abstinence Syndrome and contribute to a holistic approach to care for these vulnerable newborns.

    Related Conference of Neonatal Abstinence Syndrome

    June 22-23, 2026

    35th World Congress on Clinical Pediatrics

    Barcelona, Spain
    June 29-30, 2026

    6th Global Summit on Pediatric Nursing

    Barcelona, Spain
    July 27-28, 2026

    3rd World Pediatric Conference

    London, UK
    August 18-19, 2026

    8th World Pediatric Infectious Disease Congress

    Paris, France
    September 07-08, 2026

    24rd World Congress on Clinical Pediatrics

    Toronto, Canada
    September 14-15, 2026

    26th Annual Congress on Pediatrics & Neonatology

    Rome, Italy
    November 19-20, 2026

    37th European Pediatrics Conference

    Dubai, UAE

    Neonatal Abstinence Syndrome Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in